Altered immune cell phenotypes within chronically ischemic human kidneys distal to occlusive renal artery disease

Xiang-Yang Zhu1, Nattawat Klomjit1, Aditya S Pawar1

  • 1Division of Nephrology & Hypertension, Mayo Clinic, Rochester, Minnesota, United States.

Insights

Renal artery stenosis (RAS) causes kidney disease through inflammation. Mass cytometry revealed increased inflammatory cells and specific immune cell changes in RAS kidneys, offering potential therapeutic targets for ischemic kidney disease.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • Renal artery stenosis (RAS) is a primary cause of ischemic kidney disease, with inflammation playing a key role in its pathogenesis.
  • Understanding the immune cell landscape in ischemic kidneys is crucial for identifying disease mechanisms and potential therapeutic interventions.

Purpose of the Study:

  • To comprehensively map the single-cell immune composition in human kidneys affected by RAS using mass cytometry (CyTOF).
  • To identify specific immune cell subsets and phenotypes associated with kidney ischemia and fibrosis in RAS.
  • To compare immune cell profiles in RAS kidneys with healthy donor kidneys and kidneys with renal cell carcinoma (RCC).

Main Methods:

  • Mass cytometry (CyTOF) was employed to analyze the immune cell composition of human kidneys from patients with RAS (n=3), healthy donors (n=6), and RCC (n=3).
  • Analysis included evaluating renal fibrosis and specific macrophage populations.
  • Cytobank software was used for data analysis and visualization of cell populations.

Main Results:

  • RAS kidneys exhibited decreased epithelial cells and increased inflammatory cells (CD45+).
  • Pro-inflammatory macrophage phenotypes and reduced IL-10-producing dendritic cells (DCs) were observed in RAS.
  • Increased populations of senescent T cells, aged neutrophils, and regulatory B cells were noted in RAS kidneys, alongside increased fibrosis.

Conclusions:

  • Mass cytometry (CyTOF) is effective in detecting significant changes in renal and immune cells in ischemic kidneys due to RAS.
  • RAS is characterized by a shift towards pro-inflammatory immune cell phenotypes and increased fibrosis.
  • The identification of increased pro-repair cell types warrants further investigation for potential immune-based therapies in RAS.